生命科学资讯

FDA’s rare pediatric disease voucher program revived by 2026 government funding bill

UK consortium to use 10x Genomics platform for AI-driven cancer research - Investing.com Canada

FTC settles insulin lawsuit with Express Scripts

AbbVie says immunology blockbusters will be 'main drivers' of growth post-Humira

Novartis shakes up early pipeline with 6 culls and 2 new cancer candidates

Lilly drops 3 pipeline drugs, including gene therapy, from $1B Prevail buyout

Is Thermo Fisher Scientific (TMO) Pricing Look Reasonable After Recent Share Price Weakness - simplywall.st

Rare pediatric PRV program reauthorized until 2029 via government funding law

Trump signs funding bill with PBM reforms, hospital-at-home and telehealth extensions

Financings for Feb. 4, 2026

In the clinic for Feb. 4, 2026

Other news to note for Feb. 4, 2026

Regulatory actions for Feb. 4, 2026

BARDA offers $100M in prize money for antiviral development

PharosAI and 10x Genomics partner to transform cancer research with AI and spatial biology - marketscreener.com

Novo shares tumble by double digits on grim sales outlook

Lilly soars again as fast-selling weight loss drugs top Wall Street projections

GSK's new CEO looking for $2B to $4B deals 'hiding in plain sight'